Podcast

I Shouldn’t Be This Sleepy: A Look into EDS

Launch Date
08/28/2020
Credit Amount
0.00 Expired
Credit Expires
08/28/2021

Faculty

Richard K. Bogan, MD, FCCP, FAASM
Associate Clinical Professor
University of South Carolina Medical School
Columbia, SC
Medical University of South Carolina
Charleston, SC
Principal, Bogan Sleep Consultants, LLC
Columbia, SC
Richard K. Bogan, MD, FCCP, FAASM

Dr. Bogan is the President of Bogan Sleep Consultants, LLC. He is also Associate Clinical Professor at the University of South Carolina School of Medicine and Associate Clinical Professor at the Medical University of South Carolina in Charleston, SC.

Dr. Bogan received his bachelor’s degree in chemistry from Wofford College and his MD degree from the Medical University of South Carolina in Charleston. He served his internship and residency, as well as Chief Medical Resident, at the University of Alabama Hospital and Clinics in Birmingham. Thereafter, he completed a fellowship and assistant professorship in the Pulmonary Division of the Department of Medicine at the University of Alabama School of Medicine. He has been certified by the American boards of Sleep Medicine, Internal Medicine, and Pulmonary Diseases.

Dr. Bogan has served as principal investigator on numerous clinical trials in the past and continues to do so now. He has a variety of publications and research interests that focus on topics such as narcolepsy, insomnia, sleep apnea, shift work sleep disorder, restless legs syndrome/periodic limb movement disorder, chronic fatigue/fibromyalgia, and circadian rhythm abnormality.

Nancy R. Foldvary-Schaefer, DO, MS, FAASM, FAAN, FAES, FACNS
Professor of Neurology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Director, Cleveland Clinic Sleep Disorders Center, Cleveland, OH
Nancy R. Foldvary-Schaefer, DO, MS, FAASM, FAAN, FAES, FACNS

Dr. Nancy Foldvary-Schafer currently serves as Director of the Sleep Disorders Center and staff in the Adult Epilepsy Center at the Cleveland Clinic in Cleveland, Ohio. She is Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. Certified by the American Board of Neurology and Psychiatry in Neurology, Clinical Neurophysiology, Sleep Medicine and Epilepsy Medicine, she has treated patients with sleep disorders and epilepsy at the Cleveland Clinic since 1995. Under her leadership, the Cleveland Clinic Sleep Medicine program has undergone substantial growth including the establishment of 10 sleep laboratories and a multidisciplinary physician team spanning across neurology, psychiatry, psychology, pulmonary medicine, family and internal medicine, and pediatric specialties. She has served as a lead investigator on epilepsy, sleep apnea and narcolepsy clinical trials and has written extensively on sleep and epilepsy and women’s health and epilepsy. In 2016, Dr. Foldvary-Schaefer was appointed to the Cleveland Clinic Board of Governors. She serves on numerous national, regional, and local committees and is the author of two books and the lead editor of two books including Sleep Disorders: A Case a Week from the Cleveland Clinic, 2nd Edition, published in 2019. Also, in 2019, she received the Women’s Professional Staff Association Champion Award. She is the recipient of a $2.1 million philanthropic gift to advance education and awareness of sleep disorders.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credits

Statement of Need

Patients with narcolepsy can have a wide range of medical comorbidities, which contribute to the burden of disease as well as under diagnosis. Additionally, excessive sleepiness may persist despite patients using their CPAP for ≥ 6 hours per night. Early detection of and treatment initiation for EDS is imperative; therefore, clinicians should query their patients abut sleep, identify EDS with an evidence-based tool such as a Sleep Inventory, Polysomnography (PSG), or Mean Sleep Latency Test (MSLT).

In this CMEOCast podcast episode, expert faculty discuss how to recognize the burden imposed by EDS in patients with OSA or narcolepsy, the use of evidence-based tools to improve detection, and strategies for identifying patients in whom it is appropriate to initiate treatment for EDS.

Learning Objectives

At the end of this CME/CE activity, participants should be able to identify the burden of EDS on patient functioning and QoL, highlighting the need for early detection and treatment initiation.

Financial Support

Supported by an educational grant from Jazz Pharmaceuticals, Inc.

Target Audience

Sleep specialists, pulmonologists, neurologists, psychiatrists, primary care physicians, pediatricians, PAs, nurse practitioners, and pharmacists.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABPN MOC

ABPN Diplomates may select any CME activity relevant to their practice to count towards ABPN MOC requirements.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to PAs

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Bogan reports that he is a consultant for Harmony Biosciences, LLC; and Jazz Pharmaceuticals, Inc. He has done industry funded research for Avadel/Flamel Ireland LTD; Axsome Therapeutics, Inc.; Balance; Eisai Inc.; Fresca; Jazz Pharmaceuticals, Inc.; and Merck & Co., Inc. He is on the speakers bureau for Jazz Pharmaceuticals, Inc.; and Merck & Co., Inc. He is a shareholder, Board of Directors, Chief Medical Officer, and employee of SleepMed, Inc. He receives other financial or material support as a member of the Board of Directors, First Community Corporation, SC; and National Sleep Foundation.

Dr. Foldvary-Schaefer reports that she receives research support from Jazz Pharmaceuticals, Inc.; Suven Life Sciences; and Takeda Pharmaceuticals U.S.A., Inc. She is on the advisory committee for Jazz Pharmaceuticals, Inc.

Tony Graham, MD (peer reviewer) has no disclosures to report.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report.

Kashemi Rorie, PhD (planning committee) has no disclosures to report.

Evan Luberger (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-115-H01-P.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

 

 

PD-031-082820-43

I Shouldn’t Be This Sleepy: A Look into EDS
Event Date: 08/28/2020